WallStSmart

United States Cellular Preferred 5.500% due 2070 (UZE)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

WELL leads profitability with a 12.1% profit margin vs 0.0%. WELL earns a higher WallStSmart Score of 57/100 (C).

UZE

Avoid

29

out of 100

Grade: F

Growth: 3.3Profit: 5.0Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: 1.00

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 5.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for UZE.

WELLSignificantly Overvalued (-83.9%)

Margin of Safety

-83.9%

Fair Value

$126.32

Current Price

$230.30

$103.98 premium

UndervaluedFair: $126.32Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

UZE1 strengths · Avg: 9.0/10
Return on EquityProfitability
24.2%9/10

Every $100 of equity generates 24 in profit

WELL3 strengths · Avg: 9.0/10
Revenue GrowthGrowth
39.1%10/10

Revenue surging 39.1% year-over-year

Market CapQuality
$169.78B9/10

Large-cap with strong market position

EPS GrowthGrowth
35.6%8/10

Earnings expanding 35.6% YoY

Areas to Watch

UZE4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.9%3/10

ROE of 2.9% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
105.2x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : UZE

The strongest argument for UZE centers on Return on Equity.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap, EPS Growth. Revenue growth of 39.1% demonstrates continued momentum.

Bear Case : UZE

The primary concerns for UZE are Revenue Growth, EPS Growth, Profit Margin.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 105.2x leaves little room for execution misses.

Key Dynamics to Monitor

UZE profiles as a value stock while WELL is a growth play — different risk/reward profiles.

WELL is growing revenue faster at 39.1% — sustainability is the question.

WELL generates stronger free cash flow (881M), providing more financial flexibility.

Monitor REIT - RESIDENTIAL industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WELL scores higher overall (57/100 vs 29/100) and 39.1% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

United States Cellular Preferred 5.500% due 2070

REAL ESTATE · REIT - RESIDENTIAL · USA

United States Cellular Preferred 5.500% due 2070 offers a strategic investment within the telecommunications sector, featuring a stable fixed dividend yield of 5.500%. As a preferred equity security of United States Cellular Corporation, it reflects the company's commitment to providing reliable income amidst market fluctuations. The long maturity until 2070 affords institutional investors the potential for capital appreciation while benefiting from the company's ongoing initiatives to improve operational efficiency and grow its customer base. With a forward-looking approach to navigating industry challenges, United States Cellular is well-positioned to deliver sustainable shareholder value, enhancing the appeal of this preferred stock for yield-focused investment strategies.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?